The Globe and Mail reports in its Thursday, Nov. 30, edition that ATB Capital Markets analyst Frederico Gomes rates Green Thumb Industries "outperform" in new coverage. The Globe's David Leeder writes in the Eye On Equities column that Mr. Gomes targets the shares at $20. Analysts on average target the shares at $23.50. The Globe says Mr. Gomes calls Green Thumb "the offensive play on cash flow in cannabis." Mr. Gomes says in a note: "Our bullish investment thesis is based on Green Thumb's efficient operations and prudent capital allocation, with a track record of patience before executing on growth plans, thereby avoiding the leverage, overbuilding, and associated shuttering of assets experienced by some peers. ... Our bullish investment thesis is based on Green Thumb's efficient operations and prudent capital allocation, with a track record of patience before executing on growth plans, thereby avoiding the leverage, overbuilding, and associated shuttering of assets experienced by some peers. We think Green Thumb deserves a premium given its leading operational and financial performance, we view Green Thumb as the preferred multi-state operator to attract capital as new investors enter the space."